RxE2
Fargo, ND
RxE2 is the first company to make decentralized clinical trials a cost-effective reality. By integrating the practice of pharmacy into every aspect of clinical trials, RxE2 empowers local pharmacists, as trusted medication experts, to use their extensive patient insights and make clinical trials more accessible to patients, everywhere. This, in turn, vastly reduces clinical trial timelines and costs, helps patients achieve better health outcomes, and provides study sponsors with more accurate data.
rx-e2.comCompany Details
Founded
- 2020
Employees
- Between 5 - 20 employees
Raised
- $3,543,346
Headquarters Location
- Fargo, ND
Public
- No
Acquired
- No
CEO
- Gerald Finken
Founders
- Holly Cavanaugh
Company Collections
These are collections RxE2 is a part of. Click on the collection name to view similar companies.